Clinical Trial: Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy (GP Regimen) Combined with Intraoperative Arterial Infusion of Envafolimab plus Lenvatinib for Unresectable Biliary Tract Cancer: A Multicenter, Singlearm, Phase IbII Clinical Study (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy (GP Regimen) Combined with Intraoperative Arterial Infusion of Envafolimab plus Lenvatinib for Unresectable Biliary Tract Cancer: A Multicenter, Singlearm, Phase IbII Clinical Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132815

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344104

Published by HT Digital Content Services with permission from Health Daily Digest....